Trial · NCT07896967
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Successful liberation from mechanical ventilation within 28 days of enrollment | 28 days | Defined as the time from entry into the transition phase (study enrollment) to the first episode of sustained extubation, lasting at least 7 days |
| Secondary | Ventilator free days (at day 28) | 28 days | Number of ventilator free days at day 28 |
| Secondary | ICU length of stay (28 days) | 28 days | Length of ICU stay, measured in days from enrollment |
| Secondary | ICU length of stay (at day 90) | 90 days | ICU length of stay, measured in days from enrollment |
| Secondary | Mortality at day 28 | 28 days | Mortality at day 28 |
| Secondary | Mortality at day 90 | 90 days | Mortality at day 90 |
| Secondary | Incidence of weaning failure or reintubation | 7 days | reintubation within 7 days after extubation. |
| Secondary | Rate of complications | 28 days | including tracheostomy and resumption of sedatives |
| Secondary | Physiological characterization | 7 days | based on different inspiratory effort levels (ΔPocc) |
| Secondary | Incidence (AI) of patient-ventilator asynchrony | 7 days | Number of asynchronous respiratory cycles, expressed as a proportion of the total respiratory cycles recorded, overall and by PVA type. |
| Secondary | Mechanical ventilation settings | 7 days | Main parameters obtained from the mechanical ventilator to describe the population such as Tidal volume (liters), PEEP(cmH2O), peak pressure (cmH2O), pressure support (cmH2O), inspiratory time (seconds), respiratory rate (n/min), FIO2 (%), plateau pressure(cmH2O), driving pressure(cmH2O), static compliance (ml/cmH20) |
| Secondary | Gas exchange parameters | 7 days | e.g. PaO2 (mmhg), PaCO2 (mmhg) bicarbonate (mEq/L) |
| Secondary | Relevant medication | 7 days | e.g. vasoactive agents, delirium related medication |
| Secondary | Illness severity score (SOFA-score) | 7 days | SOFA-score. This score ranges from 0-24, with increasing scores reflecting more abnormal physiology and biochemistry or an increasing degree of intervention. |
| Secondary | Use of sedatives (cumulative dose and type) | 7 days | |
| Secondary | Reported delirium | 7 days | CAM-ICU |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07896967/registered